Clinical trial
Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study
NCT00477373 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00477373 |
|---|---|
| Title | Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study |
| Official title | Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study |
| Acronym | GEVANS |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | depakine chrono |
| Enrollment | 70 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2007 |
| First posted | May 23, 2007 |
| Last update posted | Dec 19, 2008 |
| Countries | Bahrain, Kuwait, Oman, Qatar |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: